Phase aims to close a US$30 million Series A private-equity fundraising round in a few months’ time. Photo: Edmond So
Phase aims to close a US$30 million Series A private-equity fundraising round in a few months’ time. Photo: Edmond So

Hong Kong biotech start-up at forefront of coronavirus fourth wave ‘firefight’ aims to increase rapid test kit output to meet surging demand

  • Phase Scientific plans to raise monthly output from 500,000 tests currently to 2 million next month and 10 million by the second quarter of next year
  • The company, backed by the likes of Bill Gates and the US government, has applied to the US Food and Drug Administration for emergency use authorisation

Topic |   Coronavirus China
Phase aims to close a US$30 million Series A private-equity fundraising round in a few months’ time. Photo: Edmond So
Phase aims to close a US$30 million Series A private-equity fundraising round in a few months’ time. Photo: Edmond So
READ FULL ARTICLE